| Literature DB >> 33372210 |
Anna Kotkansalo1,2,3, Ville Leinonen4,5,6,7, Merja Korajoki3, Katariina Korhonen8, Jaakko Rinne1,2, Antti Malmivaara3,9.
Abstract
BACKGROUND: Surgery for degenerative cervical spine disease has escalated since the 1990s. Fusion has become the mainstay of surgery despite concerns regarding adjacent segment degeneration. The patient-specific trends in reoperations have not been studied previously.Entities:
Keywords: Cervical spine; Degeneration; Population-based; Register study; Reoperation; Risk factors
Mesh:
Year: 2021 PMID: 33372210 PMCID: PMC8133327 DOI: 10.1093/neuros/nyaa464
Source DB: PubMed Journal: Neurosurgery ISSN: 0148-396X Impact factor: 4.654
FIGURE 1.The database construction flowchart. The flowchart has been modified from a previous publication.[7] FHDR = Finnish Hospital Discharge Registry, NOMESCO = Nordic Medico-Statistical Committee Classification of Surgical Procedures, PERFECT = Performance, Effectiveness and Cost of Treatment Episodes -project, WHO ICD-10 World Health Organization International Classification of Diseases, 10th revision
The Combinations of the Diagnosis (World Health Organization International Classification of Diseases, 10th revision) and Operative (Nordic Medico-Statistical Committee Classification of Surgical Procedures) Codes Used to Classify the Patients Into the Diagnosis and Technique Groups (Adapted From a Previous Publication)[7]
| Technique groups and the operative codes used | ||||
|---|---|---|---|---|
| Diagnosis group | Diagnosis codes | Decompression | Anterior decompression and fusion or arthroplasty | Posterior decompression and fusion |
| Disc protrusion | M50.0 | ABC01 | NAG40 | |
| M50.1 | ABC10 | NAG41 | ||
| M50.2 | ABC20 | NAB92 | ||
| M50.3 | ABC30 | |||
| M50.8 | ABC50 | |||
| M50.9 | ABC60 | |||
| G55.1 | ||||
| Foraminal stenosis | M47.2 | ABC30 | NAG40 | NAG42 |
| G55.2 | ABC50 | NAG41 | ||
| M99.6 | ABC99 | |||
| M99.7 | ||||
| Spinal canal stenosis | M47.1 |
| ABC21 | NAG42 |
| M47.8 | ABC50 | NAG40 | ||
| M47.9 | ABC60 | NAG41 | ||
| M48.0 | ABC99 | NAG72 | ||
| M99.2 | ||||
| M99.3 | ||||
| M99.4 | ||||
| M99.5 | ||||
| G95.2 | ||||
| G99.2 | ||||
aSix hundred eighty-eight cases with diagnosis codes consistent with spinal canal stenosis and the operative code ABC30 for foraminotomy, mostly from one hospital, were also included in the spinal canal stenosis group.
Grouping of the Comorbidities
| Comorbidity group | Comorbidity |
|---|---|
| Rheumatoid arthritis | Rheumatoid arthritis |
| Metabolic syndrome | Hypertension |
| Diabetes | |
| Hypercholesterolemia | |
| Cardiovascular | Atrial fibrillation |
| Cardiac insufficiency | |
| Coronary artery disease | |
| Cerebrovascular disease | |
| Peripheral artery disease | |
| Pulmonary | Chronic obstructive pulmonary disease asthma |
| Nervous system | Dementia |
| Demyelinating or neurodegenerative disease (other than dementia) | |
| Polyradiculopathy | |
| Parkinson's disease | |
| Epilepsy | |
| Psychiatric | Depression |
| Other mental disorder | |
| Alcohol or drug addiction | |
| Uremia or cancer | Uremia |
| Cancer | |
| Musculosceletal degeneration | Arthrosis of the shoulder joint |
| Arthrosis of the hip or knee joint | |
| Rotator cuff syndrome | |
| Fibromyalgia |
The Baseline Data on All the Patients Operated for Degenerative Cervical Spine Disease in Finland Between 1999 and 2015
| Diagnosis groups | Technique groups | ||||||
|---|---|---|---|---|---|---|---|
| All patients | Disc protrusion | Foraminal stenosis | Spinal canal stenosis | Decompression | Anterior cervical decompression and fusion | Posterior decompression and fusion | |
| Patients N, (%) | 19 377 | 6925 (35.7%) | 6874 (35.5%) | 5578 (28.8%) | 5998 (31.0%) | 13 099 (67.6%) | 280 (1.4%) |
| Male (%) | 56.1 | 52.1 | 57.6 | 59.3 | 59.4 | 54.9 | 44.3 |
| Mean age (SD) | 53.2 (11.4) | 47.5 (9.7) | 53.3 (9.0) | 60.0 (11.9) | 57.1 (12.7) | 51.1 (9.9) | 62.8 (11.5) |
| Comorbidity group (%) | |||||||
| Rheumatoid arthritis | 4.1 | 2.7 | 4.0 | 6.0 | 4.5 | 3.6 | 21.1 |
| Metabolic syndrome | 40.5 | 29.9 | 41.3 | 52.8 | 44.3 | 38.4 | 61.4 |
| Cardiovascular | 14.8 | 8.7 | 13.5 | 23.9 | 20.1 | 12.0 | 28.2 |
| Pulmonary | 16.3 | 15.3 | 16.8 | 16.9 | 15.2 | 16.8 | 17.5 |
| Nervous system | 6.0 | 3.5 | 4.5 | 11.2 | 8.4 | 4.8 | 12.5 |
| Uremia or cancer | 5.1 | 3.3 | 4.3 | 8.4 | 7.0 | 4.1 | 11.4 |
| Psychiatrica | 23.5 | 21.1 | 25.3 | 24.4 | 21.0 | 24.7 | 21.8 |
| Musculosceletal | 10.6 | 7.3 | 12.8 | 12.0 | 10.0 | 10.7 | 18.6 |
| Preoperative pain medications (%) | |||||||
| Antiepileptics | 30.3 | 26.0 | 26.0 | 21.2 | 18.0 | 36.0 | 30.7 |
| Duloxetine or amitriptyline | 12.1 | 10.0 | 14.5 | 11.7 | 9.2 | 13.4 | 10.4 |
| Weak opioid | 4.2 | 2.5 | 3.2 | 2.8 | 1.9 | 3.2 | 11.4 |
| Strong opioid | 3.3 | 2.7 | 2.0 | 2.0 | 1.8 | 2.5 | 6.1 |
| Muscle relaxants | 63.1 | 68.1 | 67.4 | 51.7 | 49.3 | 69.5 | 61.8 |
| Operations in a private hospital (%) | 4.9 | 6.4 | 2.1 | 6.6 | 7.7 | 3.7 | 0.7 |
aThe prevalence of psychiatric comorbidity is likely overestimated, as psychiatric comorbidity was recorded based on the International Classification of Diseases diagnosis codes from the Finnish Hospital Discharge Registry or the use of antidepressants. In this patient group, antidepressants can also be used for neuropathic pain.
The Follow-Up Time, Rate, and Timing of Late Reoperations (>365 Days After the Primary Operation) for all the Patients Operated for Degenerative Cervical Spine Disease in Finland Between 1999 and 2015 by Diagnosis and Technique Groups
| Diagnoses | Techniques | ||||||
|---|---|---|---|---|---|---|---|
| All | Disc protrusion | Foraminal stenosis | Spinal canal stenosis | Decompression | ACDF | ||
| Mean follow-up time (yr) (SD)a | 8.1 (4.9) | 9.0 (5.1) | 7.6 (4.7) | 7.5 (4.8) | 10.1 (5.4) | 7.1 (4.4) | 6.1 (5.3) |
| Median follow-up time (yr) (IQR) | 7.2 (4.0,11.7) | 8.3 (4.6,13.2) | 6.8 (3.8,10.8) | 6.8 (3.7,10.9) | 11.1 (5.3,14.7) | 6.3 (3.8,9.8) | 5.3 (2.8,8.2) |
| Late reoperations % (N) | 9.1 (1777) | 9.2 (634) | 11.0 (756) | 6.9 (387) | 7.9 (476) | 9.8 (1282) | 6.8 (19) |
| Mean time to late reoperation (yr) (SD) | 4.7 (3.5) | 5.5 (3.9) | 4.2 (3.0) | 4.4 (3.3) | 5.8 (4.2) | 4.3 (3.0) | 4.4 (3.0) |
| Median time to late reoperation years (IQR) | 3.6 (2.0,6.5) | 4.2 (2.4,7.8) | 3.3 (1.8,5.8) | 3.3 (2.0,6.0) | 4.6 (2.3,8.4) | 3.4 (2.0,5.8) | 4.3 (1.5,7.0) |
ACDF, anterior cervical decompression and fusion; PDF, posterior decompression and fusion; SD, standard deviation; IQR, interquartile range.
aThe follow-up time was defined as time until the first reoperation or death.
FIGURE 2.The distribution of the time to late reoperation (>365 d after the primary operation) in the individual patients primarily operated for degenerative cervical spine disease in Finland between 1999 and 2015. The median time to late reoperation was 3.6 yr in the entire cohort. Of the late reoperations, 75% occurred before 6.5 yr of the follow-up.
The Rate and Indications for Late Reoperations (>365 Days After the Primary Operation) Within the Primary Diagnosis Groups on Patients Operated for Degenerative Cervical Spine Disease in Finland Between 1999 and 2015
| Primary diagnosis group, % (N) of patients within group undergoing reoperation for the specific indication | ||||
|---|---|---|---|---|
| Reoperation indication | Disc protrusion | Foraminal stenosis | Spinal canal stenosis | Proportion of all the reoperations % (N) |
| Disc protrusion | 3.3 (229) | 1.5 (103) | 0.9 (51) | 21.6 (383) |
| Foraminal stenosis | 4.2 (293) | 7.9 (542) | 2.3 (128) | 54.2 (963) |
| Spinal canal stenosis | 1.9 (110) | 1.6 (107) | 3.6 (203) | 23.6 (420) |
| Mechanical problem | 0.0 (2) | 0 | 0 | 0.0 (2) |
| Hematomaa | 0 | 0 | 2 | 0.0 (2) |
| Atlanto-axial subluxation | 0 | 0.0 (4) | 0.0 (3) | 0.0 (7) |
| Reoperations in primary diagnosis group % (N) | 9.2 (634) | 11.0 (756) | 6.9 (387) | 1777 |
aDiagnosis based solely on the diagnosis code.
The Rate of Late Reoperations Within the Technique Groups and the Techniques Used in the Late Reoperations (>365 Days After the Primary Operation) on Patients Operated for Degenerative Cervical Spine Disease in Finland Between 1999 and 2015
| Primary technique groups, % (N) of patients within group undergoing reoperation using the specific technique | ||||
|---|---|---|---|---|
| Reoperation technique | Decompression | ACDF | Proportion of reoperations % (N) | |
| Decompression | 3.3 (199) | 2.9 (381) | 0.01 (4) | 32.9 (584) |
| ACDF | 4.3 (259) | 6.6 (868) | 0.02 (6) | 63.8 (1133) |
| 0.2 (10) | 0.2 (23) | 0.03 (8) | 2.3 (41) | |
| Complicationa | 0.1 (8) | 0.1 (10) | 0.0 (1) | 0.01 (19) |
| Reoperations in primary technique group % (N) | 7.9 (476) | 9.8 (1282) | 0.07 (19) | 1777 |
ACDF, anterior cervical decompression and fusion; PDF posterior decompression and fusion.
aBased solely on the operative code. As per the operative codes, complications include 14 operations for hematoma, 2 operations for wound infection, 3 operations for “other postoperative complication” and 1 operation for “other wound complication.”
FIGURE 3.The unadjusted survival estimates (Kaplan-Meier analysis) of all the patients operated for degenerative cervical spine disease in Finland between 1999 and 2015 for any reoperation A and for reoperation after the first postoperative year B. The estimated risk of any reoperation was 4.0% (standard error [SE] 0.001) at 1 yr, 6.3% (SE 0.002) at 2 yr, 10.3% (SE 0.002) at 5 yr, 14.6% (SE 0.003) at 10 yr, and 17.6% (SE 0.004) at 15 yr. The estimated late reoperation risk was 2.4% (SE 0.001) at 2 yr, 6.6% (SE 0.002) at 5 yr, 11.1% (SE 0.003) at 10 yr, and 14.2% (SE 0.004) at 15 yr. The estimated late reoperation risk at 10 yr and at 15 yr was 12.6% (SE 0.006) and 17.1% (SE 0.008) in the 18- to 44-yr-olds, 11.7% (SE 0.004) and 14.3% in the 45- to 60 -yr-olds, 8.1% (SE 0.006) and 10.1% (SE 0.008) in the 61- to 75 -yr-olds, and 3.0% at both time points (SE 0.008) in the patients over the age of 75 yr.
The Number of Reoperations and the Kaplan-Meier Estimates for the Rate of Reoperations for Adults Having Undergone a Primary Operation for Degenerative Cervical Spine Disease in Finland Between 1999 and 2015
| Follow-up (yr) | Patients at risk | Cumulative late reoperations | Estimated rate of late reoperations | SE of estimate |
|---|---|---|---|---|
| 2 | 17 865 | 441 | 2.4 | 0.001 |
| 4 | 14 560 | 969 | 5.5 | 0.002 |
| 6 | 11 378 | 1277 | 7.7 | 0.002 |
| 8 | 8725 | 1473 | 9.5 | 0.002 |
| 10 | 6447 | 1605 | 11.1 | 0.003 |
| 12 | 4589 | 1695 | 12.5 | 0.003 |
| 14 | 2996 | 1740 | 13.6 | 0.003 |
| 16 | 1660 | 1765 | 14.6 | 0.004 |
| 18 | 501 | 1776 | 15.7 | 0.005 |
SE, standard error.
FIGURE 4.The reoperation rates in the diagnosis groups depending on the technique. The late (>365 d after the primary operation) reoperation rates (% of primary operations) for the patients primarily operated for degenerative cervical spine disease in Finland between 1999 and 2015 within the diagnosis groups depending on the operative technique. In disc protrusion (DP) patients, the rates of reoperation were statistically significantly higher in patients undergoing anterior cervical decompression and fusion (ACDF) compared to decompression patients (P = .01). In the spinal canal stenosis (SCS) group, the reoperation rates were also statistically significantly different depending on the technique used (P < .001). The patients having undergone ACDF had a significantly higher (P < .05) reoperation rate compared with decompression patients, while the differences in reoperation rates between posterior decompression and fusion (PDF) and decompression or ACDF were not statistically significant. In the foraminal stenosis (FS) group, the reoperation rates were not statistically significantly different between the technique groups.
Risk Factors for Late (>365 Days After Primary Operation) Reoperation on all the Patients Operated for Degenerative Cervical Spine Disease in Finland Between 1999 and 2015 (Adjusted Cox Regression Analysis)
| Rate of reoperations, % | Hazard ratio of reoperations (CI) | Significance | |
|---|---|---|---|
| Diagnosis group | |||
| Disc protrusion | 9.2 | 1.0 | |
| Foraminal stenosis | 11.0 | 1.38 (1.23-1.54) | <.001 |
| Spinal canal stenosis | 6.9 | 1.11 (0.96-1.27) | .436 |
| Technique group | |||
| Decompression | 7.9 | 1.0 | |
| Anterior decompression and fusion | 9.8 | 1.33 (1.18-1.51) | <.001 |
| Posterior decompression and fusion | 6.8 | 1.31 (0.82-2.09) | .253 |
| Gender | |||
| Male | 9.8 | 1.0 | <.001 |
| Female | 8.4 | 0.79 (0.72-0.87) | |
| Age group | |||
| 18-44 | 11.5 | 1.0 | |
| 45-60 | 9.8 | 0.84 (0.75-0.94) | .002 |
| 61-75 | 6.2 | 0.68 (0.57-0.81) | <.001 |
| Over 75 | 2.1 | 0.33 (0.20-0.55) | <.001 |
| Comorbidity group | |||
| Rheumatoid arthritis | 8.3 | 1.10 (0.86-1.41) | .436 |
| Metabolic syndrome | 8.2 | 1.01 (0.91-1.13) | .801 |
| Pulmonary | 10.4 | 1.30 (1.15-1.47) | <.001 |
| Nervous system | 7.3 | 1.00 (0.80-1.25) | .979 |
| Uremia or cancer | 5.3 | 0.80 (0.61-1.06) | .125 |
| Psychiatric | 9.4 | 1.03 (0.91-1.16) | .609 |
| Musculosceletal degeneration | 9.1 | 1.16 (0.99-1.36) | .060 |
| Cardiovascular | 6.3 | 0.84 (0.72-0.99) | .037 |
| Hospital type | |||
| Public | 9.3 | 1.57 (1.19-2.07) | .001 |
| Private | 3.0 | 1.0 | |
| Preoperative medication | |||
| Antiepileptic drugs | 8.9 | 1.10 (0.98-1.24) | .095 |
| Amitriptyline or duloxetine | 9.8 | 1.08 (0.92-1.27) | .332 |
| Weak opiates | 10.1 | 1.40 (1.11-1.77) | .005 |
| Strong opiates | 9.2 | 1.01 (0.77-1.32) | .959 |
| Muscle relaxants | 9.6 | 1.19 (1.07-1.32) | .001 |
| Operation years | |||
| 1999-2001 | 10.6 | 1.0 | .171 |
| 2002-2004 | 11.1 | 1.11 (0.94-1.32) | .227 |
| 2005-2007 | 11.8 | 1.26 (1.06-1.50) | .008 |
| 2008-2010 | 9.9 | 1.16 (0.96-1.39) | .125 |
| 2011-2012 | 8.1 | 1.20 (0.98-1.48) | .085 |
| 2013-2015 | 5.3 | 1.24 (1.00-1.54) | .046 |
CI, confidence interval.
FIGURE 5.The risk of reoperation within the diagnosis A, technique B, gender C, age D, and primary operation year E groups. The adjusted multistep hazard curves illustrating the risk of reoperation for the patients primarily operated for degenerative cervical spine disease in Finland between 1999 and 2015 within the diagnosis groups A, within the technique groups B, between the genders C, within the age groups D, and within the primary operation year groups E. The risk of reoperation was 38% higher in the foraminal stenosis group compared with the disc protrusion group (P < .001), while the difference between the spinal canal stenosis and disc protrusion groups was not significant. The anterior cervical decompression and fusion patients (ACDF) had a 33% higher risk of reoperation compared with decompression patients (P < .001), while the difference between the posterior decompression and fusion (PDF) and decompression groups was not significant. Female patients had a 27% lower risk of reoperation compared with male patients (P < .001). The risk of reoperation was the highest in the youngest age group and lower with each consecutive age group. The risk of reoperation in the oldest age group was only 33% of the risk in the youngest age group. Compared to the years 1999-2001, the risk of reoperation was significantly higher between 2005-2007 and 2013-2015 only. The preoperative use of weak opioids (codeine or tramadol) increased the risk of reoperation by 40%, while the use of strong opioids (morphine, hydromorphone, oxycodone or fentanyl) did not influence the reoperation risk. Patients taking muscle relaxants preoperatively had a 19% higher risk of reoperation compared to those not taking muscle relaxants. Patients with pulmonary comorbidities had a higher and patient with cardiovascular comorbidities a lower risk of reoperation.
FIGURE 6.The risk of reoperation for the disc protrusion A, foraminal stenosis B, and spinal canal stenosis C groups depending on the technique used. The adjusted, multistep hazard curves illustrating the risk of reoperation for the patients primarily operated for degenerative cervical spine in Finland between 1999 and 2015 in the disc protrusion A, foraminal stenosis B, and spinal canal stenosis C groups depending on the operative technique. The risk of reoperation did not differ between the decompression and the anterior cervical decompression and fusion (ACDF) patients in the disc protrusion group, but in the foraminal stenosis group the hazard ratio (HR) of reoperation was 1.53 (95% CI 1.24-1.89, P < .001) in the ACDF patients compared to decompression and in the spinal canal stenosis group the HR of reoperation in the ACDF patients was 1.48 (95% CI 1.18-1.86, P = .001) compared to decompression. The HR of reoperation in the posterior decompression and fusion (PDF) technique group was not statistically different from decompression in either diagnosis group.
FIGURE 7.The risk of reoperation in the decompression A and anterior cervical decompression and fusion B and groups depending on the diagnosis. The adjusted, multi-step hazard curves illustrating the risk of reoperation for the patients primarily operated for degenerative cervical spine disease in Finland between 1999 and 2015 across the technique groups depending on the diagnosis: the decompression patients A and anterior cervical decompression and fusion (ACDF) patients B. In the ACDF group, the risk of reoperation was significantly higher in both the foraminal stenosis patients (HR 1.52, 95% CI 1.34-1.72, P < .001) and spinal canal stenosis patients (HR 1.23, 95% CI 1.03-1.45, P = .019) compared to disc protrusion patients. In the decompression and PDF groups, the risk of reoperation was not statistically significantly different between the diagnosis groups (there were only 19 reoperations in the PDF group, hazard curve not shown). Note the difference in scaling to Figures 5 and 6.
FIGURE 8.The factors affecting the time to reoperation: diagnosis A, age group B, and operation year C. The adjusted, multistep hazard curves illustrating the time to late reoperation for the patients primarily operated for degenerative cervical spine disease in Finland between 1999 and 2015 by diagnosis group A, patient age group B, and operation year range C. The time to late reoperation decreased from the youngest to the oldest age group and from the earlier to the later time periods. Foraminal stenosis patients and spinal canal stenosis patients underwent reoperations at an earlier time point compared to disc protrusion patients. The operative technique did not affect the time to late reoperation in the multivariate analysis.
Literature Review of Population-Based Series Describing Rates of Late Reoperations for Degenerative Cervical Spine Disease
| Author | Patients and data source | Years, follow-up | Diagnoses and techniques | Reoperation rates | Risk factors for reoperation |
|---|---|---|---|---|---|
| All techniques | |||||
| King et al, 2009[ | 12 338 patients with degenerative cervical spine disease; from Washington SID[ | 1998-2002, median follow-up 2.3 yr | Degenerative cervical spine disease | 5.6% reoperations; 2.5%/yr | Higher risk: male gender (IRR 1.17), younger age, herniated disc with myelopathy (IRR 1.32) |
| Park et al, 2016[ | 9071 patients with cervical radiculopathy or myelopathy; discectomy with anterior fusion, corpectomy, laminectomy with or without fusion or laminoplasty (LMP) as a primary procedure; from Korean HIRA[ | Primary operation in 2009, followed until June 30, 2014; follow-up of 3.5 to 4.5 yr | Cervical radiculopathy or myelopathy | Reoperation rate 3.31% | Higher risk: laminoplasty (HR[ |
| Puvanesarajah et al, 2017[ | 55 346 patients undergoing ACDF, corpectomy (ACCF[ | 2005-2012; follow-up up to 5 yr | 1-2-level ACDF, 1-2 level ACCF, 1-2 level PCF, 3 or more levels PCF | Younger age group: 1-2 level ACDF 13.8%, 1-2 level PCF 11.8%, 1-2 level ACCF 16.7%, 3 + level PCD 11.3% | Higher risk in the younger age group (<65 yr): ACDF OR[ |
| Anterior decompression | |||||
| Kelly et al, 2018[ | 52 395 patients with single-level degenerative disc disease undergoing ACDF or TDR[ | 2003-2010; follow-up up to 5 yr | ACDF or TDR | Overall late reoperation rate 2.7/100 patient years | Older age, HR 1.01; African-American, HR 1.27 |
| Park et al, 2016[ | 7948 patients operated by ACDF technique for cervical radiculopathy or myelopathy; identified from Korean HIRA national database | Primary operation in 2009, followed until June 30, 2014; minimum follow-up of 4.5 yr; mean follow-up period 4.92 yr | Cervical radiculopathy or myelopathy | Reoperation rate 2.45%; | Higher risk: myelopathy, HR 1.43; diabetes, HR 1.54; hospital types, comorbidity, HR 1.39 |
| Veeravagu et al, 2014[ | 12 744 patients undergoing single- or multilevel ACDF for any indication, from the MarketScan research Database | 2006-2010, minimum follow-up 2 yr, mean follow-up 3.2 (single-level) and 3.1 (multilevel) yr | Any indication | 9.1% revisions in single-level and 10.7% revisions in multilevel ACDFs | Multilevel operation, OR 1.1 |
| Wu et al, 2012[ | 19 385 ACDF surgeries; from the National Health Insurance Research Database (NHIRD) of Taiwan | 1997-2007; minimum follow-up 1 yr | ACDF | 2nd ACDF 2.9%, 3rd ACDF 0.15% | Male gender, HR 1.27 |
| Wu et al, 2019[ | 38 149 ACDF surgeries; from the National Health Insurance Research Database (NHIRD) of Taiwan | 1998-2013; follow-up until the end of 2013, mean follow-up 6.2 ± 3.9 yr | ACDF | 2nd ACDF, 2.9% at the mean of 4.7 yr; incidence 4.64/1000 person-years | Male gender, HR 1.13 |
| Posterior decompression | |||||
| Sayari et al, 2017[ | 6527 patients undergoing single-level posterior foraminotomy from the PearlDiver database | 2007-2011; follow-up of | Posterior cervical foraminotomy | 8.3% reoperations within 1 yr, 9.8% reoperations within 2 yr and 10.5% within 4 yr | Age under 65 yr; highest in the 50- to 54-yr age group |
| Veeravagu et al, 2018[ | 2613 patients undergoing cervical laminoplasty from the Thomson Reuters MarketScan Commercial Claims and Encounters and Medicare Supplemental and Coordination of Benefits databases | 2007-2014; mean follow-up 2.2 yr | 52.4% cervical spondylotic myelopathy, 19.3% cervical spinal stenosis, 10.6% disc disorder with myelopathy, 4.7% spondylosis without myelopathy, 1.9% disc displacement without myelopathy, 1.3% disc degeneration | 10.9% reoperations; 4.2% after the first postoperative year | Not analyzed |
| Anterior versus posterior operation | |||||
| Lin et al, 2016[ | 8183 patients undergoing multilevel ACDF or LMP[ | 2001-2011; follow-up | 80.7% ACDF, 19.3% LMP | Incidence of reoperations after 1 yr in the LMP group 0.06/100 000 person months and in the ACDF group 0.04/100 000 person months | Higher risk: history of osteoarthritis, HR 2.07 in the ACDF group but not in the LMP group; diabetes in the LMP group, HR 3.27 |
| Cervical fusion for any indication | |||||
| Derman et al, 2016[ | 87 042 patients undergoing isolated primary subaxial arthrodesis from New York Department of Health's Statewide Planning and Research Cooperative System database | 1997-2012; median follow-up 70 mo, IQR 28-120 mo | All subaxial cervical arthrodeses | Revision rate 7.7%; probability of revision at 16 yr follow-up 12.6% | Risk factors for revision: age group 35-49 yr or under; Workers’ Compensation or Medicare; white or black ethnicity; spinal stenosis HR 1.12, spondylosis HR 1.12, deformity HR 1.32, neoplasm HR 1.61 |
aSID, Washington State Inpatient Database.
bIRR, incidence rate ratio.
cHIRA, Korean Health Insurance Review and Assessment Service.
dACDF, anterior cervical decompression and fusion.
eHR, hazard ratio.
fCI, confidence interval.
gACCF, anterior cervical corpectomy and fusion.
hPCF, posterior cervical foraminotomy.
iOR, odds ratio.
jTDR , total disc replacement.
kOSHPD, California's Office of Statewide Health Planning and Development Database.
lLMP, laminoplasty.